Product
AI AGENTS
AI APPLICATIONS
OTHERS
Solutions
INDUSTRIES
Pricing
Resources
EXPLORE
ENGAGE
SUPPORT & SERVICES
About
PatSnap Eureka Platform
Agents for IP
Agents for Engineering
Agents for Life Sciences
Agents for Materials
Analytics
IP IntelligenceSynapse
Biopharma IntelligenceBio
Biosequence Search and AnalysisChemical
Chemical Structure Search and AnalysisEureka AI Inside
Professional Services
Customer Stories
Blog
Global Innovation Report
Glossary
Webinars & Training
Frontier
User Community
Trust and Security
PatentBench
LLM
Help center
Careers
Access to over 2,000,000,000 structured data points around patents, science, litigation, and tech sectors
Innovate 75% faster at 25% less cost
Cloud or on-prem for maximum privacy and control
Trusted by more than 18,000 innovators worldwide
To use , click the vertification button in the email we sent to [email protected].
This helps keep your account secure.
You should receive it shortly. Don’t forget to check your spam folder.
Thoughtfully curated series offering valuable insights for innovation professionals
Article | Report Bimekizumab vs secukinumab: head-to-head trial data, patent evidence, and mechanistic rationale for dual IL-17A/F blockade across psoriasis, axSpA, and HS.
Article | Report How selective androgen receptor degraders (SARDs) use the ubiquitin-proteasome system to overcome LBD mutations and AR-V7 splice variants driving mCRPC resistance.
Article | Report Deep analysis of Novartis patent WO2015009616A1: Iptacopan Factor B inhibitor binding pocket interactions, selectivity SAR, ADME/PK, and piperidine vs pyrrolidine scaffold comparison.
Article | Report LK-99 debunked, hydride systems hitting 556K, and zero ambient-pressure candidates validated. The room-temperature superconductor landscape in 2026, fully mapped.
Article | Report Patent CN115485277B reveals Zongertinib's 133× HER2/EGFR selectivity, cysteine engagement strategy, and 19 lead compounds with sub-nanomolar IC50 values.
Article | Report CagriSema (amylin/GLP-1) vs. Tirzepatide (GIP/GLP-1): mechanistic differences, clinical trial data, weight loss outcomes, and cardiometabolic profiles compared.
Article | Report How Micron's 621 HBM patents and SK Hynix's 50% market share define the HBM2E-to-HBM4 race. Deep-dive patent strategy, DRAM architecture, and 2026 outlook.
Article | Report Deep analysis of WO2019044947A1: T-DXd GGFG linker chemistry, DXd payload conjugation, DAR 7-8 optimization, and how these structural innovations widen the therapeutic index vs. T-DM1.
Article | Report How CNS-penetrant BTK inhibitors tolebrutinib and fenebrutinib target smoldering neuroinflammation differently from anti-CD20 therapies in MS.
Article | Report How Broadcom's 80% Ethernet switching market share and Marvell's custom AI ASIC partnerships are reshaping data center networking from 2018–2026. Patent analysis of 250+ filings.
Article | Report 124,263 active patents, two divergent markets: how wearable health sensors and industrial robotics tactile sensors are reshaping the $2.21B stretchable electronics landscape.
Article | Report Analyse BeiGene's BTK degrader BGB-16673 (Catadegbrutinib): PROTAC linker architecture, E3 ligase recruitment, DC50 values, and key patent family findings.
Article | Report How does TL1A inhibition differ from anti-TNF and anti-integrin therapies in IBD? Explore tulisokibart and RVT-3101 clinical data, mechanisms, and non-responder potential.
Article | Report Direct drive vs. geared offshore wind drivetrains in 2026: bearing materials innovation, ceramic hybrids, and the $10.6B bearing market analysed.
Article | Report ASML's lithography roadmap from DUV to High-NA EUV: 4,995 patents, 220 WPH throughput, and 0.55 NA systems enabling 8nm single-exposure resolution for sub-2nm nodes.